Related Experiment Video
Updated: Jan 20, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Subclinical and Asymptomatic Atrial Fibrillation: Current Evidence and Unsolved Questions in Clinical Practice
Andrea Ballatore1, Mario Matta2, Andrea Saglietto1
1Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Insights
This review examines treatments for asymptomatic atrial fibrillation (AF). While anticoagulation improves prognosis, rhythm control benefits quality of life, with catheter ablation showing observational promise but lacking randomized trial confirmation.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Research
Background:
- Atrial Fibrillation (AF) diagnosis varies from symptomatic presentation to incidental electrocardiogram (ECG) findings or asymptomatic detection via implanted devices.
- Anticoagulation therapy significantly improves prognosis based on individual risk profiles.
- Rhythm control strategies primarily enhance quality of life for AF patients.
Purpose of the Study:
- To review current evidence on treating subclinical and asymptomatic AF.
- To discuss the potential advantages of rhythm control therapies in this patient group.
- To identify and address existing uncertainties in the management of asymptomatic AF.
Main Methods:
- Literature review of observational data and randomized trials.
- Analysis of treatment outcomes for atrial fibrillation.
- Synthesis of evidence regarding anticoagulation and rhythm control strategies.
Main Results:
- Observational data suggest AF catheter ablation offers benefits in mortality, stroke incidence, and cognitive impairment prevention compared to medical treatment.
- Randomized trials have not consistently confirmed these observational findings for catheter ablation.
- Anticoagulation demonstrates clear prognostic benefits, while rhythm control impacts quality of life.
Conclusions:
- The management of asymptomatic and subclinical AF requires further clarification, particularly regarding the role of rhythm control therapies.
- Discrepancies between observational data and randomized trials for catheter ablation highlight areas needing further investigation.
- Balancing prognostic benefits of anticoagulation with quality-of-life improvements from rhythm control is key in AF management.
Abstract:
Atrial Fibrillation (AF) may be diagnosed due to symptoms, or it may be found as an incidental electrocardiogram (ECG) finding, or by implanted devices recordings in asymptomatic patients. While anticoagulation, according to individual risk profile, has proven definitely beneficial in terms of prognosis, rhythm control strategies only demonstrated consistent benefits in terms of quality of life. In fact, evidence collected by observational data showed significant benefits in terms of mortality, stroke incidence, and prevention of cognitive impairment for patients referred to AF catheter ablation compared to those medically treated, however randomized trials failed to confirm such results. The aims of this review are to summarize current evidence regarding the treatment specifically of subclinical and asymptomatic AF, to discuss potential benefits of rhythm control therapy, and to highlight unclear areas.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
The Evidence for Evolution
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Electrical Current
Characteristics of Practical Op Amps
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...

